TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-28,01425,15619,718
Cost of Revenue10,59110,18810,8258,804
Gross Profit16,52817,82614,33110,914
Operating Expenses
Research Development-5,1526,9512,792
Selling General and Administrative20,78025,45434,28430,372
Non Recurring----
Total Operating Expenses38,18343,99055,29344,722
Operating Income or Loss-11,064-15,976-30,137-25,004
Income from Continuing Operations
Total Other Income/Expenses Net-5,037-3,944-3,0921,282
Earnings Before Interest and Taxes-11,064-15,976-30,137-25,004
Interest Expense-4,269-4,003-2,023-2,023
Income Before Tax--19,920-33,229-23,722
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--19,920-33,229-23,722
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--19,920-33,229-23,722
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--19,920-33,229-23,722